(Q42937217)

English

Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function

scientific article published on 13 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function (English)

1 reference

Europe PubMed Central

11 November 2017

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

11 November 2017

Hans Erik Bøtker

11

1 reference

Europe PubMed Central

11 November 2017

object named as

Henrik Wiggers

12

0 references

Torsten Toftegaard Nielsen

9

object named as

Torsten Toftegaard Nielsen

1 reference

Europe PubMed Central

11 November 2017

6

object named as

Roni Nielsen

1 reference

Europe PubMed Central

11 November 2017

Helene Nørrelund

2

object named as

Helene Nørrelund

1 reference

Europe PubMed Central

11 November 2017

1

object named as

Mads Halbirk

1 reference

Europe PubMed Central

11 November 2017

4

object named as

Ole Schmitz

1 reference

Europe PubMed Central

11 November 2017

Jens Erik Nielsen-Kudsk

7

object named as

Jens Erik Nielsen-Kudsk

1 reference

Europe PubMed Central

11 November 2017

Søren Steen Nielsen

8

object named as

Søren Steen Nielsen

1 reference

Europe PubMed Central

11 November 2017

author name string

Liv Gøtzsche

5

1 reference

Europe PubMed Central

11 November 2017

Hans Eiskjær

10

1 reference

Europe PubMed Central

11 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 August 2010

1 reference

Europe PubMed Central

11 November 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

11 November 2017

299

1 reference

Europe PubMed Central

11 November 2017

4

1 reference

Europe PubMed Central

11 November 2017

H1220-5

1 reference

Europe PubMed Central

11 November 2017

Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Glucose uptake in the chronically dysfunctional but viable myocardium.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Uncoupling proteins in human heart

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

The failing heart--an engine out of fuel

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

The adrenergic-fatty acid load in heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Chamber‐specific expression of human myocardial proteins detected by two‐dimensional gel electrophoresis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Myocardial substrate metabolism in the normal and failing heart

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Metabolic remodelling of the failing heart: beneficial or detrimental?

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Decreased Myocardial Free Fatty Acid Uptake in Patients With Idiopathic Dilated Cardiomyopathy: Evidence of Relationship With Insulin Resistance and Left Ventricular Dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00475.2010

21 January 2018

Identifiers

10.1152/AJPHEART.00475.2010

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42937217&oldid=1974068787"